Get started
Leap Therapeutics, Inc.Leap Therapeutics, Inc.Leap Therapeutics, Inc.

Leap Therapeutics, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsSeasonalsOptionsETFs

LPTX chart


Full chart

LPTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.11 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.5907 USD
Net income (FY)
‪−67.56 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪33.39 M‬
Beta (1Y)
1.79

Employees


Employees (FY)
52
Change (1Y)
−2 −3.70%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.30 M‬ USD

About Leap Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Doug E. Onsi
Website
leaptx.com
Headquarters
Cambridge
Founded
2011
ISIN
US52187K2006
FIGI
BBG00DQ929W6
Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Check out other big names from the same industry as LPTX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LPTX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs with LPTX exposure


PINK
Simplify Health Care ETF
Weight
0.44%
Market value
‪712.19 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of LPTX is 0.5335 USD — it has decreased by −26.92% in the past 24 hours. Watch Leap Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Leap Therapeutics, Inc. stocks are traded under the ticker LPTX.
LPTX stock has risen by 55.13% compared to the previous week, the month change is a 81.46% rise, over the last year Leap Therapeutics, Inc. has showed a −78.05% decrease.
LPTX reached its all-time high on Apr 12, 2018 with the price of 102.5000 USD, and its all-time low was 0.2223 USD and was reached on Apr 4, 2025. View more price dynamics on LPTX chart.
See other stocks reaching their highest and lowest prices.
LPTX stock is 72.86% volatile and has beta coefficient of 1.79. Track Leap Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Leap Therapeutics, Inc. there?
Today Leap Therapeutics, Inc. has the market capitalization of ‪22.11 M‬, it has increased by 47.74% over the last week.
Yes, you can track Leap Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Leap Therapeutics, Inc. is going to release the next earnings report on Nov 17, 2025. Keep track of upcoming events with our Earnings Calendar.
LPTX earnings for the last quarter are −0.40 USD per share, whereas the estimation was −0.29 USD resulting in a −37.93% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Leap Therapeutics, Inc. earnings.
LPTX net income for the last quarter is ‪−16.64 M‬ USD, while the quarter before that showed ‪−15.44 M‬ USD of net income which accounts for −7.83% change. Track more Leap Therapeutics, Inc. financial stats to get the full picture.
No, LPTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 5, 2025, the company has 52 employees. See our rating of the largest employees — is Leap Therapeutics, Inc. on this list?
Like other stocks, LPTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Leap Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Leap Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Leap Therapeutics, Inc. stock shows the sell signal. See more of Leap Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.